Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Adrenal Disorders
Does the imaging finding of central necrosis of an adrenal tumor, biochemically confirmed as pheochromocytoma, increase the risk of malignancy?
Related Questions
Does Entresto interfere with the measurement of ARR (Aldosterone to Renin Ratio) when working up a patient for hyperaldosteronism?
Is a baseline cortisol at 0 minutes necessary to do as part of an ACTH stimulation test when performing the test in late morning or in the afternoon?
When starting stress dose steroids for patient with primary adrenal insufficiency, how do you decide whether to start hydrocortisone 100 mg every 8 hours versus 50 mg every 6 hours?
How do you counsel younger patients regarding long-term radiologic monitoring of non-functional adrenal adenomas?
Do you recommend combined baseline cortisol and DHEA-S testing to improve the efficiency and accuracy of adrenal insufficiency diagnosis?
Can norethindrone, depakote or olanzapine interfere with the results of the 1mg overnight dexamethasone suppression test for hypercortisolism screening?
Do you recommend using a 24-hour urinary cortisol/urinary creatinine ratio over a 24 hour urine cortisol to screen patients for Cushing's syndrome?
How will the newer JCEM guidelines on primary aldosteronism (PA) impact your management and screening of PA?
How do you approach treatment of a patient with bilateral adrenal gland thickening & biochemical evidence of ACTH-independent hypercortisolism?
Do you recommend checking plasma metanephrine levels during adrenal venous sampling to assist in assessing lateralization in primary aldosteronism?
